Back to search

Article

Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma

2026-04-09

Abstract excerpt

Long-term follow-up of the CASSIOPEIA trial ( NCT02541383 ) demonstrated superior progression-free survival (PFS) with daratumumab, both in combination with bortezomib, thalidomide, and dexamethasone during induction and consolidation, and during maintenance therapy, in transplant- eligible patients newly diagnosed with multiple myeloma (MM). However, outcomes among CASSIOPEIA patients remain heterogeneous across...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0400193d-d190-5157-92aa-9e9b9f60e51b
DOI
10.64898/2026.04.07.716874
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myelomaDOI 10.64898/2026.04.07.716874
Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma (MM)Semantic proximity
Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myelomaSemantic proximity
High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitionsSemantic proximity
A gene expression signature based on cell-death related gene expression in multiple myelomaSemantic proximity
Longitudinal multi-omic profiling uncovers immune escape and predictors of response in multiple myelomaSemantic proximity
Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profilingSemantic proximity
Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical OutcomesSemantic proximity
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.Semantic proximity
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myelomaSemantic proximity
Single‐cell RNA‐seq reveals clonal diversity and prognostic genes of relapsed multiple myelomaSemantic proximity
Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myelomaSemantic proximity
Risk score constructed with neutrophil extracellular traps-related genes predicts prognosis and immune microenvironment in multiple myelomaSemantic proximity
Select a neighboring publication to make it the new centre.